Table 3.
Outcome of non-parametric analysis of changes over time, individual comparison of days 30, 60, and 90 values vs. day 0, and comparison of arms A and B at corresponding times
| Value of F from anova | Outcome of Friedman Non-parametric test | Comparison of changes over day 0 baseline for arm A vs. arm B (Kuskal-Wallis test)* | ||||||
|---|---|---|---|---|---|---|---|---|
| 0 vs. 30 | 0 vs. 60 | 0 vs. 90 | Day 30 | Day 60 | Day 90 | |||
| Body weight | Arm A | 3.91 (P < 0.01) | P < 0.01 | P < 0.03 | ||||
| Arm B | ||||||||
| Systolic blood pressure | Arm A | 4.0 (P < 0.01) | P < 0.002 | P < 0.02 | P < 0.05 | |||
| Arm B | ||||||||
| Diastolic blood pressure | Arm A | 6.48 (P < 0.001) | P < 0.01 | P < 0.001 | P < 0.001 | |||
| Arm B | 3.63 (P < 0.02) | P < 0.002 | P < 0.05 | |||||
| Heart rate | Arm A | P < 0.05 | ||||||
| Arm B | ||||||||
| Serum atorvastatin | Arm A | 3.01 (P < 0.05) | P < 0.01 | P < 0.05 | P < 0.001 | P < 0.01 | ||
| Arm B | 6.91 (P < 0.001) | P < 0.001 | P < 0.001 | |||||
| Total cholesterol | Arm A | P < 0.002 | ||||||
| Arm B | 4.70 (P < 0.005) | P < 0.05 | P < 0.001 | |||||
| Triglycerides | Arm A | |||||||
| Arm B | 7.67 (P < 0.001) | P < 0.05 | P < 0.001 | P < 0.001 | ||||
| HDL | Arm A | 11.2 (P < 0.001) | P < 0.001 | P < 0.001 | P < 0.001 | |||
| Arm B | 12.9 (P < 0.001) | P < 0.001 | P < 0.001 | P < 0.001 | ||||
| LDL | Arm A | P < 0.05 | P < 0.001 | |||||
| Arm B | 6.44 (P < 0.001) | P < 0.02 | P < 0.05 | P < 0.001 | ||||
| LDL : HDL ratio | Arm A | 3.27 (P < 0.05) | P < 0.05 | P < 0.01 | P < 0.01 | P < 0.005 | P < 0.01 | |
| Arm B | 24.4 (P < 0.001) | P < 0.001 | P < 0.001 | P < 0.001 | ||||
| Physical well-being (PCS) | Arm A | |||||||
| Arm B | 4.37 (P < 0.01) | P < 0.005 | P < 0.002 | |||||
| Emotional well-being (MCS) | Arm A | 4.75 (P < 0.005) | P < 0.02 | P < 0.002 | P < 0.002 | P < 0.002 | ||
| Arm B | 4.30 (P < 0.01) | P < 0.02 | P < 0.002 | |||||
| Myalgia score | Arm A | 3.52 (P < 0.02) | ||||||
| Arm B | ||||||||
| Memory score | Arm A | P < 0.05 | ||||||
| Arm B | ||||||||
Serum atorvastatin concentrations at corresponding times were compared as actual values, not changes. No entry indicates lack of statistical significance. Friedman test was applied only if the anova was significant.